Vazegepant (Zavegepant) 是鼻内CGRP受体拮抗剂，有潜力用于偏头痛急性研究。
| 生物活性 | Vazegepant is the first intranasalCGRP receptorantagonist for the study the acute research of migraine[1][2]. |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
